2013
Tidligere
Master i farmasi Kateřina Nezvalová-Henriksen ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: The safety of antimigraine, analgesic, and antiinflammatory drugs during pregnancy. Results from the Norwegian Mother and Child Cohort Study, the Medical Birth Registry of Norway, and the Norwegian Prescription Database.
Siv.Ing. Ove Alexander Høgmoen Åstrand ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Drug discovery and design: Lead identification and discoveries made with zinc chelators, Liver X Receptor modulators and prodrug strategies.
Cand.pharm. Nataša Nikolić ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Regulation of energy metabolism in cultured human skeletal muscle cells. Effects of in vitro manipulations and donor differences.
Cand.pharm Rune Amundsen ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Pharmacokinetic drug-drug interactions involving calcineurin inhibitors - A comparison of cyclosporine A and tacrolimus as perpetrators and victims in drug-drug interactions.
Master i farmasi Anne Cathrine Vestrheim ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Glycosylation patterns of human immunoglobulin G - recombinant IgG, vaccine-induced IgG and allo-immune specific IgG.
Cand. pharm. Karen A. Boldingh Debernard ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Neuronal death or survival - nuclear receptor NGFI-B and ERK1/2 as molecular mediators.
M.Sc. Maria Teresa Calejo ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Thermoresponsive polymers in controlled drug delivery and gene delivery.
Cand. pharm. Ingjerd Sæves ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Pharmacokinetics, pharmacodynamics and pharmacogenetics of immunosuppressants in liver transplant recipients.
M.Sc. Caroline Stokke ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Determination of cell cycle parameters based on computer simulations, and organization of newly replicated DNA in Escherichia coli and Vibrio cholerae.
Cand. pharm. Hanne Lund ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Targeted Proteomics Applied in Clinical Diagnostics and Doping Analysis - Immuno-MS based Determination of Human Chorionic Gonadotropin.
Cand. pharm. Ingvild Austarheim ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Structures, and immunomodulating and anti-ulcer activities of polysaccharides from Malian medicinal plants.
Master i teknologi Siril Skaret Bakke ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Regulation of energy metabolism in human skeletal muscle cells. Effects of fatty acids, in vitro exercise and extreme obesity with and without type 2 diabetes.
Cand. pharm. Karine Wabø Ruud ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Challenges in the antiretroviral therapy program in the Eastern Cape Province, South Africa: A study of health care providers and their management of HIV patients in a sub-district of Cacadu
Cand. pharm. Gry Vibeke Bakken ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Pharmacokinetic variability of quetiapine and the active metabolite N-desalkylquetiapine.
Master i farmasi Ravinder Singh ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Investigation and development of aqueous curcumin preparations for photodynamic therapy by use of nanovehicles.
M.Sc. Yasser Mahmoud Ali Mohamed ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Synthesis and Biological Evaluation of Polyunsaturated Natural Products and Derivatives.
Cand.scient Øyvind Jacobsen ved Farmasøytisk institutt vil forsvare sin avhandling for graden ph.d: Synthesis and Structural Studies of Conformationally Constrained 310-Helical Peptides and Potential Aquaporin-4 Ligands.